These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 18474481)

  • 1. Therapeutic options in an immunocompromised patient with pemphigus vulgaris: potential interest of plasmapheresis and extracorporeal photochemotherapy.
    Saraceno R; Ruzzetti M; Lanti A; Marinacci M; Chimenti S
    Eur J Dermatol; 2008; 18(3):354-6. PubMed ID: 18474481
    [No Abstract]   [Full Text] [Related]  

  • 2. Penicillamine-induced pemphigus foliaceus-like dermatosis. A case with unusual features, successfully treated by plasmapheresis.
    Bahmer FA; Bambauer R; Stenger D
    Arch Dermatol; 1985 May; 121(5):665-8. PubMed ID: 3158288
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Trials with therapeutic plasmapheresis in pemphigus vulgaris].
    Neppert J; Meissner K; Voigt H; Meigel W
    Z Hautkr; 1980 Jun; 55(12):783-9. PubMed ID: 7415360
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Treatment of pemphigus vulgaris with plasmapheresis].
    Woscoff A; Di Lonardo AM; Remondino G; Carballo G; Laviano N; Ledesma L; Jaimovich L
    Medicina (B Aires); 1988; 48(4):395-400. PubMed ID: 3255031
    [No Abstract]   [Full Text] [Related]  

  • 5. Advances in pemphigus therapy.
    Prajapati V; Mydlarski PR
    Skin Therapy Lett; 2008 Apr; 13(3):4-7. PubMed ID: 18506357
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Treatment of pemphigus with plasmapheresis].
    Friedman-Birnbaum R; Schechter Y; Bochner H
    Harefuah; 1989 Sep; 117(5-6):135-7. PubMed ID: 2485756
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Pemphigus vulgaris--malignant course].
    Steiner A; Diem E
    Hautarzt; 1986 Sep; 37(9):499-502. PubMed ID: 3533847
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Novel therapies for pemphigus vulgaris: an overview.
    Perez OA; Patton T
    Drugs Aging; 2009; 26(10):833-46. PubMed ID: 19761276
    [TBL] [Abstract][Full Text] [Related]  

  • 9. New and innovative interventions in the management of pemphigus.
    Frydman AS; Fairley JA
    G Ital Dermatol Venereol; 2011 Jun; 146(3):211-24. PubMed ID: 21566551
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Exacerbation of pemphigus after influenza vaccination.
    De Simone C; Caldarola G; D'agostino M; Zampetti A; Amerio P; Feliciani C
    Clin Exp Dermatol; 2008 Nov; 33(6):718-20. PubMed ID: 18681883
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Continuous plasma filtration. Experiences in the treatment of pemphigus vulgaris].
    Vennemann F; Schedel A; Lorenzen M
    Z Hautkr; 1984 Aug; 59(16):1075-9. PubMed ID: 6485455
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Plasmapheresis as a supplementary treatment in pemphigus.
    Błaszczyk M; Chorzelski T; Daszyński J; Gaczkowski A; Jabłońska S; Beutner EH
    Arch Immunol Ther Exp (Warsz); 1981; 29(6):763-7. PubMed ID: 7349095
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Adjuvant therapy of pemphigus with plasmapheresis].
    Török L; Borka I; Reszler M; Tóth E
    Orv Hetil; 1981 Sep; 122(38):2349-51. PubMed ID: 7312354
    [No Abstract]   [Full Text] [Related]  

  • 14. [The immunocorrective and detoxifying actions of hemosorption, plasmapheresis and enterosorption in pemphigus].
    Grebennikov VA; Beliaevskiĭ AD; Kaminskiĭ MIu; Kuzina ZA; Litvinenko TA
    Vestn Dermatol Venerol; 1990; (5):33-8. PubMed ID: 2402939
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An alternate explanation for the decrease in pemphigus antibodies with combination treatment of double-filtration plasmapheresis and IVIg.
    Habib N; Bystryn JC
    Eur J Dermatol; 2009; 19(2):190; author reply 191. PubMed ID: 19106059
    [No Abstract]   [Full Text] [Related]  

  • 16. Severe pemphigus vulgaris: successful combination therapy of plasmapheresis followed by intravenous high-dose immunoglobulin to prevent rebound increase in pathogenic IgG.
    Aoyama Y; Nagasawa C; Nagai M; Kitajima Y
    Eur J Dermatol; 2008; 18(5):557-60. PubMed ID: 18693160
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pemphigus, pregnancy, and plasmapheresis.
    Shieh S; Fang YV; Becker JL; Holm A; Beutner EH; Helm TN
    Cutis; 2004 May; 73(5):327-9. PubMed ID: 15186047
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Treatment of autoimmune disease with extracorporeal photochemotherapy: pemphigus vulgaris--preliminary report.
    Rook AH; Heald PW; Nahass GT; Macey W; Witmer WK; Lazarus GS; Jegasothy BV
    Yale J Biol Med; 1989; 62(6):647-52. PubMed ID: 2636804
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pemphigus: update for the general practitioner.
    Stoopler ET; Pinto A; DeRossi SS
    N Y State Dent J; 2003; 69(7):30-2. PubMed ID: 14552023
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Complete remission of drug-resistant Pemphigus vegetans treated by extracorporeal photopheresis.
    Kaiser J; Kaatz M; Elsner P; Ziemer M
    J Eur Acad Dermatol Venereol; 2007 Jul; 21(6):843-4. PubMed ID: 17567330
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.